Published in Food Chem Toxicol on March 14, 2002
Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco. Cancer Epidemiol Biomarkers Prev (2009) 1.30
The need for a new toxicity testing and risk analysis paradigm to implement REACH or any other large scale testing initiative. Arch Toxicol (2007) 1.11
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol (2013) 0.96
Update on methodologies available for ciguatoxin determination: perspectives to confront the onset of ciguatera fish poisoning in Europe. Mar Drugs (2010) 0.87
Effects of in vitro brevetoxin exposure on apoptosis and cellular metabolism in a leukemic T cell line (Jurkat). Mar Drugs (2008) 0.84
Cytogenetic damage induced by mouthrinses formulations in vivo and in vitro. Clin Oral Investig (2011) 0.82
Genotoxicity and cytotoxicity of glass ionomer cements on Chinese hamster ovary (CHO) cells. J Mater Sci Mater Med (2006) 0.81
Orthodontic cements induce genotoxicity and cytotoxicity in mammalian cells in vitro. Dent Res J (Isfahan) (2012) 0.79
Fluorescence imaging for a noninvasive in vivo toxicity-test using a transgenic silkworm expressing green fluorescent protein. Sci Rep (2015) 0.79
Analysis of individual and combined effects of ochratoxin A and zearalenone on HepG2 and KK-1 cells with mathematical models. Toxins (Basel) (2014) 0.79
Impairment of the cell-to-matrix adhesion and cytotoxicity induced by the Mediterranean jellyfish Pelagia noctiluca venom and its fractions in cultured glioblastoma cells. Lipids Health Dis (2012) 0.78
The role of mitochondria in T-2 toxin-induced human chondrocytes apoptosis. PLoS One (2014) 0.77
Four New Sulfated Polar Steroids from the Far Eastern Starfish Leptasterias ochotensis: Structures and Activities. Mar Drugs (2015) 0.77
In vitro testing of basal cytotoxicity: Establishment of an adverse outcome pathway from chemical insult to cell death. Toxicol In Vitro (2016) 0.76
Application of Gut Cell Models for Toxicological and Bioactivity Studies of Functional and Novel Foods. Foods (2012) 0.75
A toxicology suite adapted for comparing parallel toxicity responses of model human lung cells to diesel exhaust particles and their extracts. Aerosol Sci Technol (2015) 0.75
An optimization protocol for Swiss 3T3 feeder cell growth-arrest by Mitomycin C dose-to-volume derivation strategy. Cytotechnology (2017) 0.75
Validation of the dynamic direct exposure method for toxicity testing of diesel exhaust in vitro. ISRN Toxicol (2013) 0.75
Photodynamic Inactivation Mediated by Erythrosine and its Derivatives on Foodborne Pathogens and Spoilage Bacteria. Curr Microbiol (2015) 0.75
Assessment of cytotoxicity, genotoxicity and 7-ethoxyresorufin-O-deethylase (EROD) induction in sediment extracts from New Zealand urban estuaries. Ecotoxicology (2017) 0.75
In vitro impact of five pesticides alone or in combination on human intestinal cell line Caco-2. Toxicol Rep (2014) 0.75
Application of the rainbow trout derived intestinal cell line (RTgutGC) for ecotoxicological studies: molecular and cellular responses following exposure to copper. Ecotoxicology (2017) 0.75
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia (2009) 2.30
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia. Blood (1995) 2.00
Transcriptional regulation of two genes specifically induced by glucose starvation in a hamster mutant fibroblast cell line. J Biol Chem (1983) 1.96
Ehrlichia-like 16S rDNA sequence from wild white-tailed deer (Odocoileus virginianus). J Parasitol (1996) 1.74
Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands. Leukemia (2004) 1.71
Biological and therapeutic aspects of infant leukemia. Blood (2000) 1.70
Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs. Blood (1998) 1.69
Reducing delusional speech in chronic, paranoid schizophrenics. J Appl Behav Anal (1973) 1.68
Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia (2008) 1.67
Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia. J Clin Oncol (2003) 1.67
mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL. Leukemia (2005) 1.63
Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem Toxicol (2004) 1.60
Relation between genetic variants of the ataxia telangiectasia-mutated (ATM) gene, drug resistance, clinical outcome and predisposition to childhood T-lineage acute lymphoblastic leukaemia. Leukemia (2005) 1.53
An improved MTT assay. J Immunol Methods (1993) 1.52
The MLL recombinome of acute leukemias. Leukemia (2006) 1.51
Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia (2003) 1.46
Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004. Leukemia (2009) 1.45
Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia? Leukemia (1999) 1.44
Ultrafine but not fine particulate matter causes airway inflammation and allergic airway sensitization to co-administered antigen in mice. Clin Exp Allergy (2006) 1.43
Organotin-induced apoptosis as observed in vitro is not relevant for induction of thymus atrophy at antiproliferative doses. Toxicol Appl Pharmacol (1997) 1.42
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia. Br J Cancer (2005) 1.41
The non-genotoxicity to rodents of the potent rodent bladder carcinogens o-anisidine and p-cresidine. Mutat Res (1991) 1.41
Assessment of the short-term functional outcome after urethroplasty: a prospective analysis. Int Braz J Urol (2012) 1.41
Amphibian pancreas function in long-term organ culture: control of amylase release. Gen Comp Endocrinol (1977) 1.39
Electrocardiogram of the humpback whale (Megaptera novaeangliae), with specific reference to atrioventricular transmission and ventricular excitation. J Am Coll Cardiol (1992) 1.39
Attitudes to alternatives to animal experimentation. Altern Lab Anim (2001) 1.38
Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledge. Toxicology (2004) 1.38
Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences. Leukemia (2007) 1.36
Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica (2002) 1.33
In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood (1997) 1.28
MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia (2011) 1.26
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia (2007) 1.25
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol. Leukemia (2009) 1.24
Estimate of the genome size by renaturation studies in Streptomyces. Appl Microbiol (1975) 1.24
Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML). Leukemia (2002) 1.22
The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia. Leukemia (2011) 1.21
Non-disjunction and crossing-over induced by pharmaceutical drugs in Aspergillus nidulans. Mutat Res (1974) 1.21
Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. Blood (1999) 1.20
Guidance for the safety assessment of botanicals and botanical preparations for use in food and food supplements. Food Chem Toxicol (2003) 1.19
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia (2008) 1.18
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia (2013) 1.16
Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia. Med Pediatr Oncol (1996) 1.15
Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia. Leukemia (2011) 1.15
New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis. J Appl Toxicol (2013) 1.14
Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study. Leukemia (2008) 1.12
Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. Eur J Cancer (2013) 1.12
Cultivation in vitro of normal and neoplastic cells of Xenopus laevis. Exp Cell Res (1966) 1.11
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia. Blood (2000) 1.10
Acute stroke therapy trials: problems in patient accrual. Stroke (1988) 1.09
Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. Ann Oncol (2009) 1.08
Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia (2012) 1.08
Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro. Chem Biol Interact (1991) 1.08
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia. Leukemia (2010) 1.07
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia (2012) 1.06
Mutagenic and recombinogenic action of pesticides in Aspergillus nidulans. Mutat Res (1977) 1.06
Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol (2010) 1.06
Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis. Gynecol Oncol (1998) 1.05
A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 1.05
mRNA expression levels of methotrexate resistance-related proteins in childhood leukemia as determined by a standardized competitive template-based RT-PCR method. Leukemia (2000) 1.05
The hunting of targets: challenge in miRNA research. Leukemia (2012) 1.05
Transfer of antibiotic resistance genes between yeast and mammalian cells under conditions favoring cell fusion. Somat Cell Mol Genet (1986) 1.05
The volume effect in paediatric oncology: a systematic review. Ann Oncol (2013) 1.04
Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis (2001) 1.04
Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia. Leukemia (2011) 1.04
Interobserver reliability of detecting lumbar intervertebral disc high-intensity zone on magnetic resonance imaging and association of high-intensity zone with pain and anular disruption. Spine (Phila Pa 1976) (1998) 1.03
Long-term efficacy of catheter ablation for atrial fibrillation: impact of additional targeting of fractionated electrograms. Heart (2010) 1.03
Hepatic metabolism of diclofenac: role of human CYP in the minor oxidative pathways. Biochem Pharmacol (1999) 1.02
The threshold of toxicological concern concept in risk assessment. Toxicol Sci (2005) 1.02
Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia. Leukemia (2004) 1.01
Glucocorticoid resistance in childhood leukemia. Leuk Lymphoma (1994) 1.01
Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia (2010) 1.01
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model. Leukemia (2011) 1.01
Exposure to benzene and urinary concentrations of 8-hydroxydeoxyguanosine, a biological marker of oxidative damage to DNA. Occup Environ Med (1994) 1.01
'Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000)'. Leukemia (2010) 1.00
The FRAME multicentre project on in vitro cytotoxicology. Food Chem Toxicol (1987) 1.00
Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target. Leukemia (2012) 1.00
[Biochemical characterization of certain mutants of Streptomyces coelicolor requiring histidine]. Ann Ist Super Sanita (1966) 0.99
Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay. Br J Cancer (1994) 0.99
Risk characterisation of chemicals in food and diet. Food Chem Toxicol (2003) 0.99
Assessment of intake from the diet. Food Chem Toxicol (2002) 0.98
Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity. Toxicol Appl Pharmacol (2000) 0.98
L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage. Pediatr Blood Cancer (2005) 0.98
The effect of the food matrix on in vivo immune responses to purified peanut allergens. Toxicol Sci (2005) 0.98
In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype. Leukemia (2004) 0.97
Gain of 1q is a marker of poor prognosis in Wilms' tumors. Genes Chromosomes Cancer (2013) 0.97
Hazard characterisation of chemicals in food and diet. dose response, mechanisms and extrapolation issues. Food Chem Toxicol (2002) 0.96
CD4+CD25+ T cells regulate the intensity of hypersensitivity responses to peanut, but are not decisive in the induction of oral sensitization. Clin Exp Allergy (2007) 0.96
A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia. Leukemia (2006) 0.95
The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005. Leukemia (2005) 0.95
The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia. Int J Clin Pharmacol Ther (2000) 0.95
Localized mutagenesis in Streptomyces coelicolor A3 (2). Mutat Res (1976) 0.95
In vivo genotoxicity of selected herbicides in the mouse bone-marrow micronucleus test. Arch Toxicol (1997) 0.95
Natural Hybrids of Phytophthora nicotianae and Phytophthora cactorum Demonstrated by Isozyme Analysis and Random Amplified Polymorphic DNA. Phytopathology (1998) 0.95
Organotins induce apoptosis by disturbance of [Ca(2+)](i) and mitochondrial activity, causing oxidative stress and activation of caspases in rat thymocytes. Toxicol Appl Pharmacol (2000) 0.95
Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia. Leukemia (2008) 0.95
High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia (2013) 0.94
Decreased serum anti-Müllerian hormone levels in girls with newly diagnosed cancer. Hum Reprod (2013) 0.94
Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome. Leukemia (2006) 0.94